Stem Cell Breakthrough Shows New Path Toward HIV Cure December 3, 2025 A recently published case has captured international scientific interest after researchers confirmed that a man living with HIV has remained free of detectable virus long after stopping treatment. He originally underwent a stem cell transplant for leukemia. The donor cells used for the […]
Skin tags may indicate insulin resistance and higher diabetes risk which makes them an important early warning sign.
A large US study reported a higher breast cancer risk among frequent users of permanent hair dye and chemical straighteners.
A peer reviewed study reveals how Epstein Barr virus reprograms B cells and activates autoimmune reactions that lead to lupus.
A new Neurology study shows that people who drink three or more alcoholic drinks a day experience bleeding strokes about eleven years earlier, with heavier vessel damage and higher odds of severe brain bleeding.
Hormone therapy remains an effective treatment for menopausal symptoms, but its heart safety depends on age. A major analysis of the Women’s Health Initiative reveals when benefits outweigh the risks.
A research team from MIT and Massachusetts General Hospital has developed AsymMirai, an AI tool that analyzes mammograms to predict breast cancer risk as far as five years ahead. By focusing on the small differences between both breasts, it offers a simpler and more interpretable way to detect risk early and potentially save lives.
A new U S study reveals that long term loss of smell remains common among adults who had COVID 19, even two years after infection. The findings highlight the importance of formal testing and early rehabilitation.
A new study published in Radiology followed 2,978 women with dense breasts and found that combining molecular breast imaging with 3D mammography detected over twice as many invasive cancers as mammograms alone, helping doctors find tumors earlier.
A study of over 8.4 million people in South Korea reported increased risks of thyroid, gastric, colorectal, lung, breast, and prostate cancers within one year of COVID-19 vaccination, highlighting the need for more research.
Asia Pacific Management and Research Group, Inc. (APMARGIN)Â
Unit 202 Metrover Building, McArthur Hi-way, Poblacion, Guiguinto, Bulacan 3015
Copyright © 2026. APMARGIN All Rights Reserved.